Aug 07, 2020 / 07:00AM GMT
Presentation
Aug 07, 2020 / 07:00AM GMT
=====================
Corporate Participants
=====================
* Khalid Waleed Hosny Al Nabilsi
Hikma Pharmaceuticals PLC - CFO
* Sigurdur Oli Olafsson
Hikma Pharmaceuticals PLC - CEO & Executive Director
=====================
Sigurdur Oli Olafsson - Hikma Pharmaceuticals PLC - CEO & Executive Director
Hello, everyone. I'm Siggi Olafsson, CEO of Hikma Pharmaceuticals, and I'm here with Khalid Nabilsi, the CFO. I'll provide an update on our strategic progress, and I'll then hand it over to Khalid to run through our financial results for the first half of 2020. We have delivered a strong first half results, which are ahead of our initial expectations. Core group revenue was $1.1 billion, up 9% over last year, reflecting a good performance in each of our 3 businesses.
In Injectables, we saw an increase in demand for our end market products, particularly those used in the treatment of COVID-19 patients under good cost control. Our Generics business also had a good start to the
Half Year 2020 Hikma Pharmaceuticals PLC Pre-Recorded Earnings Presentation Transcript
Feb 13, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers